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Introduction: ICU-acquired weakness is thought to mediate physical impairments in survivors of critical illness, but
few studies have investigated this thoroughly. The purpose was to investigate differences in post-ICU mortality and
physical functioning between patients with and without ICU-acquired weakness at 6 months after ICU discharge.
Method: ICU patients, mechanically ventilated ≥2 days, were included in a single-center prospective observational
cohort study. ICU-acquired weakness was diagnosed when the average Medical Research Council score was <4 in
awake and attentive patients. Post-ICU mortality was recorded until 6 months after ICU discharge; in surviving
patients, physical functioning was assessed using the Short-Form Health Survey physical functioning domain.
The independent effect of ICU-acquired weakness on post-ICU mortality was analyzed using a multivariable Cox
proportional hazards model. The independent effect of ICU-acquired weakness on the physical functioning
domain score was analyzed using a multivariable linear regression model.
Results: Of the 156 patients included, 80 had ICU-acquired weakness. Twenty-three patients died in the ICU (20
with ICU-acquired weakness); during 6 months follow-up after ICU discharge another 25 patients died (17 with
ICU-acquired weakness). Physical functioning domain scores were available for 96 survivors (39 patients with
ICU-acquired weakness). ICU-acquired weakness was independently associated with an increase in post-ICU
mortality (hazard ratio 3.6, 95% confidence interval, 1.3 to 9.8; P = 0.01) and with a decrease in physical functioning
(β: -16.7 points; 95% confidence interval, -30.2 to -3.1; P = 0.02).
Conclusion: ICU-acquired weakness is independently associated with higher post-ICU mortality and with clinically
relevant lower physical functioning in survivors at 6 months after ICU discharge.Introduction
After surviving critical illness, many patients suffer from
its long-term consequences, which may consist of physical
impairments, cognitive dysfunction, and mental health
problems [1]. The relevance of physical impairments was
described in acute respiratory distress syndrome survivors,
who continued to suffer from physical impairments up to
5 years after resolution of critical illness [2]. It is thought
that development of ICU-acquired weakness (ICU-AW) is
an important mediator of physical impairments [1].
However, evidence supporting this hypothesis is limited [3].* Correspondence: L.Wieske@amc.uva.nl
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unless otherwise stated.ICU-AW is a frequently occurring neuromuscular
complication of critical illness, with an estimated incidence
of 46% (95% confidence interval (CI), 43 to 49) in patients
with sepsis, prolonged mechanical ventilation or multiple
organ dysfunction syndrome [4]. ICU-AW is defined as
clinical signs of weakness that develop after the onset of
critical illness [5,6]. For diagnosing ICU-AW, muscle
strength is assessed manually [5,6]. This can be done
reliably when patients are awake and attentive [7].
Weakness may be caused by muscle and/or peripheral
nerve dysfunction and damage [5]. If differentiation between
these underlying disorders is needed, electrophysiological
testing may be performed [5].
In a cohort of acute lung injury survivors, it was found
that development of ICU-AW was associated with more
physical impairments during follow-up [8]. However, this
association was not corrected for possible confounders.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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critically ill patients and the association between ICU-AW
and long-term physical impairments in critically ill
patients in general remains to be investigated.
Besides being a possible mediator of post-ICU physical
impairments, ICU-AW also has a substantial impact on
post-ICU mortality. ICU-AW is independently associated
with increased in-hospital mortality [9,10]. Also, 1-year
mortality is worsened by ICU-AW [11].
In this 6-month follow-up study, we investigated the
impact of ICU-AW on the post-ICU period by comparing
post-ICU mortality and physical functioning between
patients with and without ICU-AW. We hypothesized
that ICU-AW is independently associated with increased
post-ICU mortality and that survivors with ICU-AW have
decreased physical functioning at 6 months after ICU
discharge.
Methods
Study design and ethical approval
We conducted a single-center prospective observational
cohort study. The institutional review board of the
Academic Medical Center, Amsterdam, the Netherlands,
decided that the study did not fulfill the criteria for
medical research as stated in the Dutch ‘Law on medical
research’ because the nature of the data collected for this
study was judged to be non-intrusive for patients
(METC 10/219) and therefore formal informed consent
procedures did not apply. Still, we sought verbal and/or
written approval of all surviving patients for participating
in this study and using their data.
Study setting
The study was performed in the closed-format tertiary,
34-bed, mixed medical-surgical intensive care unit of the
Academic Medical Center in Amsterdam, the Netherlands.
As an integral part of care, all patients received early
rehabilitation that was continued after transfer to the
regular ward until hospital discharge.
Study population
Inclusion criteria were newly admitted ICU patients
aged ≥18 years, mechanically ventilated for ≥2 days.
Exclusion criteria were neuromuscular disorders (for
example, Guillain-Barré syndrome), any type of stroke, and
out-of-hospital cardiac arrest as reasons for admission, and
quadriplegia due to a spinal cord syndrome in the medical
history or as reason for admission. Additionally, we
excluded patients in whom manual muscle strength
could not be assessed because of prolonged delirium
or failure to awake (that is, up to ICU discharge), patients
who had poor functional status before admission (modified
Rankin score ≥4 [12]) and patients with a language barrier.
Patients with pre-existing neuromuscular disorders notleading to ICU admission or a poor functional status were
included in this study. Also, patients admitted because of
central nervous system disorders not involving any type of
stroke and being awake and alert during ICU admission
(for criteria, see below) were included in this study.
Assessment of ICU-acquired weakness
ICU-AW was diagnosed using the current diagnostic
reference standard [5]. As a part of routine care, physical
therapists performed manual muscle strength assessments
using the Medical Research Council (MRC) score as soon
as patients were awake (Richmond Agitation Sedation
Scale [13] between -1 and +1) and attentive (able to follow
verbal commands using arms or eyelids). MRC scores of
six different muscle groups were measured bilaterally; that
is, wrist dorsiflexors, elbow flexors, shoulder abductors,
hip flexors, knee extensors and ankle dorsiflexors. The
scores of muscle groups were summated and divided by
the number of muscle groups that could be assessed to
obtain an average MRC score (range 0 to 5). Symmetric
weakness that had developed after ICU admission with an
average MRC score <4 was defined as ICU-AW [5].
Mortality
All-cause mortality was registered during ICU admission
and in the 6 months follow-up after the final ICU discharge
date. Mortality of patients who were lost to follow-up was
obtained by checking municipal registries.
Physical functioning
Physical functioning was assessed in patients surviving
to 6 months after the final ICU discharge date using the
36-item Short-Form health survey (SF-36) physical
functioning (PF) domain score [14,15]. To optimize
response rate, the 36-item Short-Form health survey
was assessed both by telephone interview conducted
by one of the investigators and by mail.
Baseline and clinical characteristics
During admission, we scored the presence of the following
disorders: sepsis [16], severe sepsis [17], septic shock [17]
and acute respiratory distress syndrome [18]. Additionally,
we collected the following characteristics from the elec-
tronic patient file: age, gender, body mass index (kg/m2),
Charlson co-morbidity index (ranging from 0 to 24 [19]),
admission type, Acute Physiology and Chronic Health
Evaluation (APACHE) IV score, maximal Sequential
Organ Failure Assessment score during admission, days
with mechanical ventilation, use of renal replacement
therapy, and ICU and hospital length of stay.
Statistical analysis
The primary analyses were the independent effect of
ICU-AW on post-ICU mortality and on the PF domain
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mortality was analyzed using a Cox proportional hazard
model (hazard ratio reported with 95% CI) adjusted for
confounders. Confounders were a priori defined as age,
gender, Charlson co-morbidity index, presence of septic
shock, APACHE IV score and maximal Sequential Organ
Failure Assessment score during admission [20,21]. The
independent effect of ICU-AW on the PF domain score
was assessed using a multivariable linear regression
model adjusted for the above-mentioned confounders
(regression coefficient (β) reported with 95% CI). A
difference of 10 points on the PF domain score was
defined as clinically relevant [22,23]. More detail on
statistical methodology and the results of the regression
models including the individual variables is provided in
Additional file 1. The PF domain score assessed by
telephone was used for analysis or, if unavailable, the PF
domain score assessed by mail. Agreement between the
two interview methods was assessed using the intra-class
correlation coefficient (reported with 95% CI) in patients
for whom both the telephone and mail PF domain scores
were available.
We also analyzed differences in the number of days
free from hospital and alive at 3 months after the final
ICU discharge between patients with and without ICU-AW
using the Wilcoxon rank-sum test.
For descriptive analyses, mean values are presented
with standard deviation, median values with interquartile
range, and proportions with percentages and total numbers.
Differences between proportions were assessed using
chi-square test or Fisher’s exact test. Differences between
normally distributed variables were assessed using Welch’s
t-test; differences between non-normally distributed con-
tinuous variables were assessed using Wilcoxon rank-sum
test. For correlation analyses, spearman’s rho was used in
case of ordinal variables and Pearson biserial correlation
in case of dichotomous variables.
A P value less than 0.05 was considered statistically
significant. Analyses were done using R (version: 3.0.1; R
Foundation for Statistical Computing, Vienna, Austria).
Sample size estimation
This study was powered to detect a difference of 10 points
on the PF domain score. With an alpha of 0.05, power of
80% and a common standard deviation of 10 [24], 40
patients per group would be needed. Assuming that 50%
of newly admitted ICU patients would develop ICU-AW
[4], a mortality rate of 35% after 6 months follow-up [25],
and that 10% of the population would be lost to follow-up,
a population of 140 patients was needed.
Results
Between May 2011 and January 2013 156 patients were
included, 133 of whom survived to ICU discharge. Figure 1displays the study flowchart. Patient and admission
characteristics are displayed in Table 1.
Post-ICU mortality
Post-ICU mortality was higher in patients with ICU-AW
(17/60 (28%) vs 8/73 (11%); P = 0.02). Lower average MRC
scores were correlated with higher mortality (r = -0.21;
P < 0.01). When adjusted for confounders, ICU-AW
was associated with higher post-ICU mortality until 6
months after ICU discharge (hazard ratio 3.6; 95% CI,
1.3 to 9.8; P = 0.01; two patients excluded because of
missing APACHE IV scores). Figure 2 displays the
post-ICU mortality curve. Most deaths occurred during
hospital admission; mortality rates after hospital discharge
were not different for patients with or without ICU-AW
(Table 2). The number of days free from hospital and alive
at 3 months after ICU discharge was lower for patients
with ICU-AW (Table 1). Overall mortality, including the
period of ICU admission, was 37/80 (46%) for patients
with ICU-AW and 11/76 (15%) for patients without
ICU-AW (P < 0.01).
Physical functioning
Of the 108 patients who survived up to 6 months after
ICU discharge, physical functioning was assessed in 98
patients (10 were lost to follow-up; Figure 1). Patients’
place of residence when physical functioning was
assessed is shown in Table 2. Sixty-six questionnaires
completed via telephone and 32 by mail were used for the
analyses. The intra-class correlation coefficient between the
telephone-obtained and mail-obtained PF scores was 0.88
(95% CI, 0.67 to 0.95; N = 30). The physical functioning
domain score was significantly lower in patients with
ICU-AW (Table 2). Higher average MRC scores were
correlated with higher physical functioning domain scores
(rho = 0.34; P < 0.01). After adjusting for confounders,
ICU-AW was associated with a decrease of 16.7 points on
the PF domain score (95% CI, -30.2 to -3.1; P = 0.02; 2
patients excluded because of missing APACHE IV scores).
Discussion
The results from this study show that, when assessed at
6 months after ICU discharge, ICU-AW is independently
associated with higher post-ICU mortality and with clinic-
ally relevant lower physical functioning in survivors.
We found no difference in mortality after hospital dis-
charge. However, it should be noted that, up to the point
of hospital discharge, 41% of patients with ICU-AW
had already died and the duration of hospital admission
after ICU-discharge was much longer for patients with
ICU-AW. Hermans and colleagues reported increased
1-year mortality in ICU-AW patients [11]. Additionally,
mortality was increased during ICU stay and hospital stay
in patients with ICU-AW, which has been reported before
Figure 1 Flowchart of the study population. ICU-AW, ICU-acquired weakness; OHCA, out-of-hospital cardiac arrest; MRC, muscle strength as
assessed with Medical Research Council scale; mRankin, modified Rankin score; NMD, neuromuscular disorder.
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ICU- and in-hospital mortality of 31% in patients
with ICU-AW, compared to 6% for patients without
ICU-AW. Sharshar and colleagues [10] reported similar
mortality rates (31% in patients with ICU-AW; 10% in
patients without ICU-AW). Compared to these studies,
we found a higher combined ICU- and in-hospital mortality
rate in ICU-AW patients (41%), whereas mortality in
patients without ICU-AW was similar (9%). Both studies
also based the diagnosis of ICU-AW on manual muscle
strength with a cut-off of an average MRC score <4. The
difference in mortality may be explained by differences in
case-mix and inclusion and exclusion criteria.
Increased mortality in ICU-AW may be explained by
an increased risk of developing (nosocomial) infections,
as was reported by Sharshar and colleagues [10]. The
increased risk for developing (nosocomial) infections
may be the result of increased durations of mechanical
ventilation [26,27], ICU admission [27] and hospital
admission [9], which we also found in our study.
Alternatively, an increased risk of developing infections
may be the result of immune dysfunction secondary toautonomic dysfunction that may accompany ICU-AW
[28,29]. Autonomic dysfunction in general may also
increase mortality, as was found in critically ill patients
[30]. More research is needed to establish reasons for
and prevention of mortality in ICU-AW.
In surviving patients, we found that ICU-AW is
independently associated with decreased physical
functioning. While it was known that survivors with
ICU-AW have physical impairments [8,31-33], our
study now suggests that, by comparison with critically
ill patients without ICU-AW and by correcting for
possible confounders, there is an independent effect
of ICU-AW on the outcome of critical illness survivors.
Moreover, this effect of ICU-AW seems clinically relevant,
shown by the difference of more than 10 points on the PF
domain score [22,23].
ICU-AW may cause post-ICU physical impairments
by various mechanisms. In ICU-AW, muscle and/or
nerves can be affected both on a functional and struc-
tural level [5]. Decreased excitability may cause muscle
and nerve dysfunction and this may resolve quickly [34].
In contrast, structural damage may result in long-term
Table 1 Baseline and ICU admission characteristics for patients surviving to ICU discharge
ICU-AW No ICU-AW P value
(N = 60) (N = 73)
Patient characteristics
Age, mean ± SD 65 ± 16 59 ± 14 0.03
Female, n (%) 27 (45) 30 (41) 0.78
BMI (kg/m2), mean ± SD 26.8 ± 5.1 26.9 ± 5.2 0.86
BMI >30, n (%) 14 (23) 16 (22) 1.00
Pre-existing neuromuscular disorder, n (%) 3 (5) 1 (1) 0.33
Charlson co-morbidity index, median (IQR) 0 (0-1) 0 (0-2) 0.05
ICU admission characteristics
Admission type
Medical, n (%) 34 (63) 41 (57) 0.99
Surgical elective, n (%) 15 (21) 18 (24)
Surgical emergency, n (%) 11 (16) 14 (19)
APACHE IV score, mean ± SD (2 missing) 81 ± 23 73 ± 28 0.10
CNS disorder as reason of admission, n (%) 1 (2) 0 (0) 0.45
Maximal SOFA score during admission, mean ± SD 12 ± 3 9 ± 4 <0.01
Sepsis during admission, n (%) 56 (93) 57 (78) 0.03
Severe sepsis during admission, n (%) 49 (82) 42 (58) 0.01
Septic shock during admission, n (%) 35 (58) 26 (36) 0.01
Renal replacement therapy during admission, n (%) 23 (38) 19 (26) 0.18
ARDS during admission, n (%) 28 (47) 32 (44) 0.88
Days with mechanical ventilation, median (IQR) 11 (6-17) 5 (4-7) <0.01
Length of stay in ICU (days), median (IQR) 14 (9-20) 7 (5-10) <0.01
Average MRC score, median (IQR) 2.8 (1.8-3.5) 4.7 (4-5) n.a.
Post-ICU admission characteristics
Days free from hospital and alive at 3 months after ICU discharge, median (IQR) 57 (15-71) 75 (56-82) <0.01
Discharge destination from index hospital if discharged alive
Other hospital, n/total n (%) 22/53 (41) 14/71 (20) 0.01*
Rehabilitation facility, n/total n (%) 14/53 (27) 4/71 (6)
Home, n/total n (%) 17/53 (32) 53/71 (76)
APACHE IV, Acute Physiology and Chronic Health Evaluation IV; ARDS, Acute Respiratory Distress Syndrome; BMI, body mass index; CNS, central nervous system;
ICU-AW, ICU-acquired weakness; IQR, interquartile range; MRC, muscle strength as assessed with Medical Research Council scale; SD, standard deviation; SOFA,
Sequential Organ Failure Assessment score; n.a., not applicable; *, overall test for differences between groups.
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to muscle involvement has been linked to worse out-
come [32,35,36].
Our study has some limitations. Firstly, because of the
single-center design, our results may not be fully
generalizable to other populations. The critically ill
patients included in this study may represent a relatively
healthy population, as shown by the low scores on the
Charlson co-morbidity index. Secondly, we did not use
electrophysiological studies and muscle biopsies to
differentiate between the underlying disorders causing
ICU-AW. Three disorders can cause ICU-AW; that is,
critical illness polyneuropathy, critical illness myopathy,and critical illness neuromyopathy [5]. The additional
diagnostic information obtained by electrophysiology
and muscle biopsy is unclear because this has not been
studied extensively. Three small studies described a
better outcome in critical illness myopathy compared
to critical illness polyneuropathy or critical illness
neuromyopathy [32,35,36]. Third, our finding that
mortality after hospital discharge did not differ between
groups may be the result of lack of power because our
study was not powered for this analysis. Fourth, due to the
nature of the study design, there is the possibility of
residual bias confounding the observed association
between ICU-AW and physical impairments. Fifth, we did
Figure 2 Post-ICU survival curves for patients with and without ICU-acquired weakness. Survival curves for patients with (black line) and without
(grey line) intensive care unit-acquired weakness (ICU-AW) starting at final ICU discharge until end of follow-up; that is, 6 months after final ICU
discharge. Dotted lines represent the 95% confidence interval; censored patients presented with +.
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mediate between ICU-AW and physical impairments,
such as length of stay in the ICU. Because of ICU-AW,
length of stay in the ICU will be longer [35] and the longer
length of stay may in turn result in more physical
impairments. Instead, we a priori selected confounders
from the literature that may result in physical impair-
ments in a mechanism independent of ICU-AW. Finally,
we did not investigate the impact of the observed physical
impairments on (health-related) quality of life of our
patients. Quality of life relies on many factors other than
physical functioning, such as critical illness-induced cog-
nitive dysfunction or post-traumatic stress disorders, andTable 2 Post-ICU outcomes for patients with or without ICU-a
Post-ICU mortality
In-hospital, n/total n (%)
After hospital discharge, n/total n (%)
PF domain scores at 6 months follow-up, median (IQR; n)
Patients’ residence at 6 months follow-up
Hospital, n/total n (%)
Rehabilitation facility, n/total n (%)
Home, n/total n (%)
*Overall P value for comparison of all categories. ICU-AW, intensive care unit-acquir
functioning domain score.general factors like age, pre-existing co-morbidities and
the availability of support resources and/or caregivers
[34,37].
The results of this study have several implications.
With a better understanding of the long-term impact of
ICU-AW, the prognosis may be discussed more reliably
with patients and families by neurologists and intensivists.
More information on possibly preventable causes of
death in patients with ICU-AW is needed. Furthermore,
pathophysiological mechanisms leading to ICU-AW and
its long-term sequelae should be clarified to enable
interventions preventing or attenuating ICU-AW.
Strict glycemic control and late initiation of parenteralcquired weakness
ICU-AW No ICU-AW P-value
13/60 (22) 4/73 (5) 0.01
4/47 (9) 4/69 (6) 0.71
45 (30-70; 39) 75 (50-90; 59) <0.01
0/39 (0) 4/59 (7) 0.01*
4/39 (10) 0/59 (0)
35/39 (90) 55/59 (93)
ed weakness; IQR, interquartile range; PF, Short-Form Health Survey physical
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Interventions attenuating the course of ICU-AW are not
yet available. Early rehabilitation may be interesting as this
has been shown to improve functional outcome in general
ICU patients [40].
Conclusions
We found, in patients mechanically ventilated for 2 days
or more, that development of ICU-AW was independently
associated with increased post-ICU mortality and clinically
relevant lower physical functioning at 6 months after
discharge from the ICU. These findings implicate ICU-AW
as an important mediator of physical impairments in
survivors of critical illness. As such, studies on prevention
or treatment of ICU-AW are urgently needed.
Key messages
 ICU-AW is a frequent complication of critical
illness and has been implicated as a mediator of
physical impairments in survivors of critical illness.
The exact contribution is, however, unknown.
 In this study, we found that ICU-AW was
independently associated with clinically relevant
lower physical functioning at 6 months after
discharge from the ICU.
Additional file
Additional file 1: Statistical analyses and regression models.
Additional methodology describing the statistical analyses as well as the
full regression formulae and results.
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